Generic drug of Xatral LP
Therapeutic class: Urology nephrology
active ingredients: Alfuzosin
laboratory: Evolupharm
Box of 30
All forms
Indication
· Treatment of functional symptoms of benign prostatic hypertrophy.
· Adjunctive bladder catheterization in acute urine retention related to benign prostatic hypertrophy.
Dosage ALFUZOSINE LP EVOLUGEN 10 mg Extended release film-coated tablet Box of 30
Oral way.
The tablet should be swallowed whole with a glass of water (see Warnings and Precautions ).
The recommended dosage is 1 10 mg tablet daily, to be taken immediately after the evening meal.
Adjuvant bladder catheterization in acute urine retention related to benign prostatic hypertrophy:
The recommended dosage is 1 10 mg tablet daily, to be taken after the meal, from the first day of urethral catheterization.
The treatment is administered for 3 to 4 days including 2 to 3 days during the catheterization and 1 day after the withdrawal of the latter.
Against indications
This product should not be administered in the following situations:
Hypersensitivity to alfuzosin and / or any of the other ingredients;
· orthostatic hypotension ;
· Hepatic insufficiency ;
· Severe renal impairment (creatinine clearance <30 ml / min);
Adverse effects Alfuzosine LP Evolugen
FREQUENCY | |||
ORGAN SYSTEM | Frequent | Rare | Very rare |
CNS disorders and psychiatric disorders | dizziness, dizziness, malaise, headache | dizziness, drowsiness | |
Cardiovascular disorders | tachycardia, palpitations, orthostatic hypotension, syncope | Angina pectoris in patients with a history of coronary heart disease (see Warnings and Precautions section ) | |
Respiratory system disorders | Nasal congestion |
Gastrointestinal disorders | nausea, abdominal pain | diarrhea, dry mouth | |
Skin manifestations | rashes, pruritus | Urticaria, angioneurotic edema | |
General events | asthenia | flushes, edema, chest pain (see section Warnings and precautions for use ) |